6 research outputs found
Clinical management and treatment of polydactyly
Amaç: Polidaktili sık görülen doğumsal el ve ayak anomalilerinden
biri olup, ilk defa 1670 yılında elde rapor edilmiştir. Fazla olan parmak
genellikle sadece yumuşak doku içerikli olmakla beraber nadir
olarak kemik yapı da içermektedir. Polidaktili sindaktiliye oranla üç
kat daha fazla görülmektedir. Bu çalışmada polidaktiliye yaklaşım
ve tedavi sonuçlarımız değerlendirilmiştir.
Gereç ve Yöntemler: Son 5 yılda 27 hastada elde, 20 hastada ayakta
ve 3 hastada hem elde hem ayakta (24 erkek, 26 kadın) toplam
50 hasta polidaktili tanısıyla değerlendirildi.
Bulgular: Hastaların ortalama yaşı altı (1-14) idi. Tüm hastalar genel
anestezi altında opere edildi. Lezyonlara uygulanan lokal anestezi
sonrası total derin eksizyon uygulandı. Dikişler 10-12. günlerde
alındı. Opere edilen hastalarda uzun dönemde fonksiyonel sorun
görülmedi.
Sonuç: Polidaktili tedavisinde temel hedef fazla olan dokuların
çıkarılması ve etkilenen dokuların anatomik olarak uygun şekilde
onarılmasıdır. Polidaktili sonrası hastaların yaklaşık %25'inde farklı
nedenlerle yeniden operasyon yapılmaktadır. Bu çalışmada el ve/
veya ayakta polidaktili nedeniyle opere edilen hastalar sonuçlarıyla
birlikte değerlendirilmiştir. Sonuç olarak eksizyon ve uygun
kapama basit olgular için yeterli iken, kompleks olgularda tendon,
kemik ve ligamentlerin uygun şekilde repozisyonu temel amaç olmalıdır
The protective effect of cilostazol on transverse rectus abdominis myocutaneous flap in rats
Objective: Transverse Rectus Abdominis Myocutaneous (TRAM) flap is commonly used in breast reconstruction. The aim of this study is to demonstrate the effects of cilostazol on TRAM flap viability in a rat TRAM model. Methods: Twenty-four Wistar rats were used. They were divided into four groups. Rats in Group 1 were applied TRAM flap. In Group 2, cilostazol 30 mg/kg was administered to rats via oral gavage 3 hours before the flap surgery. After the flap surgery, cilostazol 30mg/kg was administered via oral gavage twice a day for 7 days. In Group 3 before the flap surgery, cilostazol 30 mg/kg was administered via oral gavage twice a day for 7 days, and treatment continued for 7 more days after the flap surgery. In Group 4 before the flap surgery, cilostazol 30 mg/kg was administered via oral gavage twice a day for 7 days and treatment was discontinued after the flap surgery. Result: The mean necrosis rate in Group 1 was 41.69%, in Group 2 it was 27.0%, in Group 3 it was 6.66%, and in Group 4 it was 11.2%. The necrosis rate in Group 1 was found to be statistically significantly higher than other groups (p < .01), the necrosis rate in Group 2 was found to be statistically significant higher than Groups 3 and 4 (p < .01), and the necrosis rate in Group 4 was found to be statistically significant higher than Group 3 (p < .01). Conclusion: Cilostazol treatment seemed to increase the viability of TRAM flap, especially when administered as adjuvant therapy
Successful Surgical Treatment of a Necrotizing Fasciitis due to Klebsiella Pneumonia Following Open Prostatectomy
Basal Cell Carcinoma in Young Patients
Basal cell carcinoma (BCC) is the most common type of skin cancer and has a direct relationship with chronic sun exposure. Other risk factors
include fair skin and eyes, freckling, family history, genetic disorders, immunosuppression, ionizing radiation, arsenic, and polyaromatic hydrocarbons.
BCC usually progresses slowly. Lesions are usually seen over sun-exposed areas, which are most commonly on the face and neck.
Local invasion may occur, but it rarely metastasizes. The incidence of BCC peaks in the seventh decade of life. BCC is an uncommon lesion
during childhood, youth, and pregnancy. It has rarely been reported during childhood. BCC seen during childhood can be inherited with
diseases such as xeroderma pigmentosum, albinism, Bazex syndrome, and basal cell nevus syndrome or after high-dose radiotherapy. In this
study, we present the cases of a 14-year-old girl with BCC on the right popliteal region and a 23-year-old pregnant woman with BCC on the
nasal tip. Both patients underwent total excision, and there were neither recurrence nor any complication during the follow-u
Clinical Experiences in the Surgical Treatment of Accessory Tragus
Objective: Tragus is a part of the external ear that develops from the first branchial arch. Accessory ear is a congenital external ear anomaly
and has skin elevation containing remnant cartilage. The auricle develops between the 4th and 12th week of the embryonic stage,
which groove the tissue from the 1st and 2nd branchial arches. Histologically, the lesions include a rugated epidermis with a thin layer
stratum corneum, tiny mature hair follicles, fat lobules, and connective tissue framework that may include a central cartilage core. The
aim of this study was to evaluate the accessory tragus lesions with our clinical surgical treatment results.
Material and Methods: Lesions usually located anterior to the tragus and along an imaginary line drawn from the tragus to the angle of
the mouth. Twelve patients admitted to our clinic between October 2011 and November 2014 were included in this study.
Results: Seven boys and five girls between two–13 years old underwent operation. In total, 28 accessory ears were excised. No complications
were observed during the procedure, and no complaints were noted in the postoperative period.
Conclusion: Generally, limited anomaly is associated with the first and second branchial arch anomalies. Surgical excision is the standard
treatment for the lesions which usually due to the esthetic concerns